Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also looks ripe to announce a stock split. Eli Lilly's shares look attractive ...

Last night’s IT: Welcome to Derry Season 1 finale revealed that the HBO show has been even more intrinsically linked to Andy Muschietti‘s It and IT: Chapter Two than we initially thought. **Spoilers ...

Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market today and has a pipeline of promising candidates to potentially reinforce its ...

British singer Lily Allen’s appearance as the musical guest on NBC's Saturday Night Live on Saturday night sparked a sharp backlash from some viewers, with social media users questioning her vocals, ...

Lily Allen returned to the Saturday Night Live stage after nearly 19 years away with two performances from her latest pop album, West End Girl. Allen, an SNL musical guest in early 2007, opened with ...

Milana Vayntrub, an actress known for playing Lily Adams in AT&T commercials, raised $500K for Los Angeles wildfire victims by offering exclusive “flirty” photos of herself “After the L.A. fires this ...

The actress offered exclusive photographs of herself in exchange for donations Desiree Anello is a Writer/Reporter at PEOPLE. She has been working at PEOPLE since 2025. Her work has previously ...

Eli Lilly is positioned for a secular growth trajectory, leveraging its duopoly in diabetes and obesity therapies while investing heavily in pipeline diversification. LLY faces intensifying ...

Eli Lilly LLY-0.47%decrease; red down pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Retatrutide shows highest weight loss to date in trial Lilly says trial departures due to perceived excessive weight loss Retatrutide shows elevated skin-related side effects Dec 11 (Reuters) - Eli ...